The neurovascular embolization devices global market report 2024from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Neurovascular Embolization Devices Market, 2024report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size – The neurovascular embolization devices market size has grown strongly in recent years. It will grow from $1.15 billion in 2023 to $1.23 billion in 2024 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to the increased prevalence of neurovascular disorders, the rising geriatric population, the demand for minimally invasive procedures, improved healthcare infrastructure, and increased healthcare expenditure.
The neurovascular embolization devices market size is expected to see strong growth in the next few years. It will grow to $1.60 billion in 2028 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to expanding applications in emerging markets, emphasis on patient-centric care, rising awareness about neurovascular disorders, advancements in imaging technologies, and increasing investments in research and development. Major trends in the forecast period include personalized treatment approaches, integration of artificial intelligence in treatment planning, the emergence of next-generation embolic materials, shift towards outpatient and ambulatory procedures and development of innovative embolization techniques
Order your report now for swift delivery @ https://www.thebusinessresearchcompany.com/report/neurovascular-embolization-devices-global-market-report
Scope Of Neurovascular Embolization Devices MarketThe Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Neurovascular Embolization Devices Market Overview
Market Drivers -The rise in the prevalence of hemorrhages is expected to propel the neurovascular embolization devices market going forward. Hemorrhages are abnormal, uncontrolled bleeding that occurs internally within the body or externally through a break in the skin or mucous membrane. The prevalence of hemorrhages is due to several factors, such as aging populations, an increased incidence of hypertension, and the expanded use of anticoagulant medications. Neurovascular embolization devices are utilized in hemorrhagic strokes to obstruct abnormal blood vessels, reducing bleeding and preventing further damage to the brain. For instance, in February 2024, according to the research of King’s College London, a UK-based public research university, the number of cases and deaths from intracerebral hemorrhage (ICH) (a specific type of hemorrhage) is expected to increase by 59.4% in people aged 70 to 95 across the UK by 2050. Therefore, the rise in the prevalence of hemorrhages drives the growth of the neurovascular embolization devices market.
Market Trends – Major companies operating in neurovascular embolization devices are focused on developing products with advanced technology, such as shield technology, to treat brain aneurysms and gain a competitive edge in the market. Shield Technology refers to an advanced feature aimed at enhancing the efficacy and safety of the devices and contributing to the overall durability and longevity of the embolization devices. For instance, in June 2022, Medtronic PLC, an Ireland-based healthcare technology company, launched the Pipeline Vantage with Shield Technology, a fourth-generation flow diverter in India. It has enhanced design features to improve ease of use and reliability during endovascular procedures. The device promotes cell growth in the inner lining of the blood vessel, providing a scaffold that contributes to the minimally invasive treatment of aneurysms, reduces the risk of rupture, and improves patient outcomes.
The neurovascular embolization devices market covered in this report is segmented –
1) By Product: Embolization Coils, Liquid Embolic Systems, Flow Diversion Stents, Aneurysm Clips, Other Products
2) By Treatment: Ischemic Stroke Solution, Hemorrhagic Stroke Solutions
3) By Indication: Brain Aneurysms, Arteriovenous Malformation, Other Indications
4) By End User: Hospitals, Ambulatory Surgical Centers, Other End Users
Get an inside scoop of the neurovascular embolization devices market, Request now for Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15871&type=smp
Regional Insights – North America was the largest region in the neurovascular embolization devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurovascular embolization devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Key Companies – Major companies operating in the neurovascular embolization devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Heraeus Holding, Stryker Corporation, Boston Scientific Corporation, Kaneka Corporation, Terumo Corporation, B Braun Melsungen AG, Cook Medical LLC, Integer Holdings Corporation, Merit Medical Systems Inc, Penumbra Inc, Asahi Intecc Co Ltd, MicroVention Inc, Balt USA LLC, Imperative Care Inc, InNeuroCo Inc, Acandis GmbH & Co KG, Rapid Medical Ltd, Emboline Inc, InspireMD Inc, QXMedical LLC, Vesalio LLC, EmbolX Inc
Table of Contents 1. Executive Summary2. Neurovascular Embolization Devices Market Report Structure3. Neurovascular Embolization Devices Market Trends And Strategies4. Neurovascular Embolization Devices Market – Macro Economic Scenario5. Neurovascular Embolization Devices Market Size And Growth…..27. Neurovascular Embolization Devices Market Competitor Landscape And Company Profiles28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
